This federal Project Grant award of $246,521, provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports a workforce development program to train public health and clinical research professionals in West Africa. The key products and services delivered through this grant include: Establishing a training program at the University of Sciences, Techniques and Technologies of Bamako (USTTB) in Mali...
The federal Project Grant award, titled "ANTIMICROBIAL RESISTANCE TRAINING PROGRAM IN THE TEXAS MEDICAL CENTER (AMR-TPT)", is funded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The $1,026,119 award to the Methodist Hospital Research Institute (HMRI) will establish a comprehensive training program to develop the next generation of scientists and clinician-scientists focused on tackling the...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), will support a $1,553,810 research project to evaluate a genomic surveillance approach for detecting artemisinin resistance in malaria parasites in Africa. The primary awardee is the University of Maryland, Baltimore, which will collaborate with the University of Sciences, Techniques and Technologies of Bamako (Usttb) in Mali...
The federal Project Grant award with ID D43TW012726, provided by the National Institutes of Health's Fogarty International Center (CFDA 93.989 - International Research and Research Training), will fund a $962,344 initiative to strengthen capacity for policy-relevant life course epidemiological research in Ghana. The project aims to develop a sustainable pipeline of interdisciplinary African physician scientists and postdoctoral investigators focused on addressing the growing burden of...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $1,303,086 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Maryland, Baltimore to conduct the "IMPACT OF EARLY CHILDHOOD MALARIA PREVENTION ON MALARIA RISK AT SCHOOL ENTRY (ERASE)" study. This longitudinal cohort study will evaluate the epidemiological impact of seasonal malaria chemoprevention (SMC) and the RTS,S malaria vaccine on the burden of...
This $108,916 Project Grant award from the National Institutes of Health (NIH) Fogarty International Center (CFDA 93.989 - International Research and Research Training) will allow Dr. Clifford George Banda of Kamuzu University of Health Sciences in Malawi to characterize the pharmacokinetic and safety profiles of the antimalarial drugs lumefantrine and amodiaquine in two key neglected populations: African children with severe acute malnutrition and adults living with HIV on dolutegravir-based...
The National Science Foundation (NSF) awarded a $949,997 Project Grant to Iowa State University of Science and Technology under the Biological Sciences program (CFDA 47.074) to investigate the role of environmental factors in the development of antimicrobial resistance (AMR) in municipal wastewater treatment plants. The five-year research project, starting November 1, 2023, will conduct field, laboratory, and computational studies to determine how susceptible bacterial strains are replaced by...
This $153,912 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports a research study to examine the pharmacokinetics and pharmacogenomics of dolutegravir-based antiretroviral therapy in young people living with HIV in Ghana. The key objectives of the study are to: 1) Determine rates of dolutegravir-based antiretroviral therapy resistance in young people living with HIV; and 2)...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $175,000.00 to California State University, Fresno to develop a decentralized antimicrobial resistance (AMR) surveillance system in resource-limited settings. The project aims to assess the detection of drug-resistant bacteria and antimicrobial bacteriophages using cost-efficient long-read sequencing on Flongle...
The National Institute of Allergy and Infectious Diseases (NIAID), through its Allergy and Infectious Diseases Research program (CFDA 93.855), awarded a $112,943 project grant to the Jos University Teaching Hospital (JUTH) in Nigeria. The grant, titled "MICHIGAN-UNIJOS MENTORED PROGRAM FOR ENHANCED RESEARCH ADMINISTRATION (MUMPERA)", aims to build research administration capabilities and develop electronic grant management systems at JUTH and its regional partner institutions. The...